| VolitionRX now calling for key partners and collaborators to bolster large scale clinical validation LONDON, March 27, 2012 /PRNewswire/ -- The ability to diagnose disease early has long been a goal in the medical arena. VolitionRX (VNRX.OB), a life sciences company, is pioneering scientific research into simple, cost-effective tools capable of diagnosing the early presence of disease via a blood test. (Photo: http://photos.prnewswire.com/prnh/20120327/NY77344 ) VolitionRX is devel...continued VNRX |
Tuesday, March 27, 2012
Pioneering New Science Nucleosomics Advances Blood Based Diagnostics for Cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment